Technical Analysis for GTHX - G1 Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 47.64 0.21% 0.10
GTHX closed up 2.15 percent on Friday, July 20, 2018, on 43 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Aug 8

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GTHX trend table...

Date Alert Name Type % Chg
Jul 20 Bollinger Band Squeeze Range Contraction 0.21%
Jul 20 Overbought Stochastic Strength 0.21%
Jul 19 Bollinger Band Squeeze Range Contraction 2.36%
Jul 19 Stochastic Reached Overbought Strength 2.36%
Jul 19 Inside Day Range Contraction 2.36%
Jul 19 Overbought Stochastic Strength 2.36%
Jul 18 Crossed Above 50 DMA Bullish 0.21%
Jul 18 MACD Bullish Signal Line Cross Bullish 0.21%
Jul 18 Bollinger Band Squeeze Range Contraction 0.21%
Jul 18 Up 3 Days in a Row Strength 0.21%

Older signals for GTHX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
G1 Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.
Is GTHX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 52.76
52 Week Low 12.04
Average Volume 350,589
200-Day Moving Average 31.5669
50-Day Moving Average 45.7204
20-Day Moving Average 45.486
10-Day Moving Average 45.805
Average True Range 2.5717
ADX 12.58
+DI 19.5532
-DI 18.5995
Chandelier Exit (Long, 3 ATRs ) 42.2849
Chandelier Exit (Short, 3 ATRs ) 49.0051
Upper Bollinger Band 48.7855
Lower Bollinger Band 42.1865
Percent B (%b) 0.81
BandWidth 14.507761
MACD Line 0.4543
MACD Signal Line 0.2778
MACD Histogram 0.1765
Fundamentals Value
Market Cap 1.34 Billion
Num Shares 28.3 Million
EPS -11.02
Price-to-Earnings (P/E) Ratio -4.31
Price-to-Sales 0.00
Price-to-Book 4.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.74
Resistance 3 (R3) 50.66 49.53 50.20
Resistance 2 (R2) 49.53 48.71 49.56 50.02
Resistance 1 (R1) 48.53 48.21 49.03 48.61 49.85
Pivot Point 47.40 47.40 47.65 47.43 47.40
Support 1 (S1) 46.40 46.58 46.90 46.48 45.23
Support 2 (S2) 45.27 46.08 45.30 45.06
Support 3 (S3) 44.27 45.27 44.88
Support 4 (S4) 44.35